The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified

Wunan Zhou1, Meron Teklu1, Vy Bui1

  • 1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.

Insights

Systemic inflammation and early coronary artery disease (noncalcified coronary burden) both contribute to increased left ventricular mass in psoriasis patients. Noncalcified coronary burden partially mediates the link between inflammation and left ventricular mass.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Dermatology

Background:

  • Increased left ventricular (LV) mass is a significant precursor to heart failure.
  • Systemic inflammation plays a key role in the development of LV mass.
  • The specific contribution of subclinical coronary artery disease (CAD) to this inflammation-LV mass relationship remains unclear.

Purpose of the Study:

  • To investigate the association between systemic inflammation, measured by plasma glycoprotein A (GlycA), and LV mass in psoriasis patients.
  • To determine if early CAD, assessed as noncalcified coronary burden (NCB), mediates the relationship between GlycA and LV mass.
  • To evaluate the longitudinal association between changes in NCB and changes in LV mass.

Main Methods:

  • An observational longitudinal study involving 213 subjects with psoriasis and no known cardiovascular disease.
  • Measurements included plasma GlycA (nuclear magnetic resonance spectroscopy) and LV mass and NCB (coronary CT angiography).
  • 189 participants were followed for one year, with repeated measurements of LV mass and NCB.

Main Results:

  • LV mass significantly increased across tertiles of GlycA (p<0.001).
  • Both GlycA (β=0.24, p=0.001) and NCB (β=0.50, p<0.001) were independently associated with LV mass after adjusting for multiple risk factors.
  • Mediation analysis revealed that NCB accounted for 32% of the GlycA-LV mass association. Longitudinal analysis showed change in NCB independently predicted change in LV mass (β=0.25, p=0.002).

Conclusions:

  • Both systemic inflammation (GlycA) and coronary artery NCB are associated with LV mass in psoriasis patients, independent of traditional cardiovascular risk factors.
  • NCB significantly mediates the relationship between systemic inflammation and LV mass.
  • These findings highlight the potential role of early coronary atherosclerosis in linking systemic inflammation to LV mass.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
498
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
83
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
107
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
121
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
69
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
97